Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Ra Pharmaceuticals: Is Trying To Copy What Works A Good Product Development Strategy? [Seeking Alpha]

RA PHARMACEUTICALS (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors
Company Research Source: Seeking Alpha
Ra Pharmaceuticals: Is Trying To Copy What Works A Good Product Development Strategy?SummaryRa Pharma is developing RA101495, a C5 inhibitor and a potential competitor to Alexion's blockbuster Soliris.RA101495 may not have as strong commercial potential in PNH or aHUS, but I think it has significant potential in gMG.Modest market share in PNH or aHUS is possible with RA101495 treating Soliris non-responders, going to markets where Soliris is unavailable or Ra Pharma competing on price.I am initiating Ra Pharma with a buy rating and $13.5 price target.Other indications, such as lupus nephritis represent upside to the thesis. Show less Read more
Impact Snapshot
Event Time:
RARX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RARX alerts
Opt-in for
RARX alerts

from News Quantified
Opt-in for
RARX alerts

from News Quantified